The market taxonomy of coloscopy devices by types reveals distinct technological and functional subcategories. Optical Coherence Tomography (OCT) devices, used for high-resolution cross-sectional imaging, constitute 40% of the segment, leveraging their precision in detecting submucosal lesions. Confocal Laser Endomicroscopy (CLE), which enables real-time cellular-level imaging, holds 30%, driven by its role in guiding targeted biopsies. Other types, including chromoendoscopy and narrow-band imaging (NBI) systems, account for 30%, benefiting from cost-effectiveness and widespread adoption in routine screenings. This typology underscores innovation in imaging technologies, with OCT and CLE segments expanding due to their diagnostic superiority and integration with AI-driven analytics.